greeksoup/ stock research

Intuitive Surgical (ISRG) FY2009 results: revenue $1.1 billion, up 20.3% on the year

Intuitive Surgical Inc. (ISRG) reported revenue of $1.1 billion for fiscal 2009, the year ended 31 December 2009, up 20.3% on the year before. Net income was $233 million, up 13.8%, and diluted earnings per share $0.66. The figures are the company's own, from the 10-K it filed with the SEC on 29 January 2010.

Revenue
$1.1 billion
+20.3% on the year
FY2007FY2009
Operating margin
35.9%
35.5% a year earlier
FY2007FY2009
Net income
$233 million
+13.8% on the year
FY2007FY2009
Diluted EPS
$0.66
+15.8% on the year
FY2007FY2009

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2009FY2008FY2007On the yearLast 8 years
Revenue1,052875601+20.3%
Cost of revenue301254187+18.5%
Gross profit751621414+21.0%
Gross margin71.4%71.0%69.0%
Research and development95.179.448.9+19.8%
Selling, general and administrative279231159+20.8%
Operating income377311207+21.4%
Operating margin35.9%35.5%34.4%
Pre-tax income396335237+18.2%
Income tax16413192.7+24.9%
Effective tax rate41.3%39.0%39.1%
Net income233204145+13.8%
Net margin22.1%23.4%24.1%
Diluted EPS$0.66$0.57$0.41+15.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2009FY2008FY2007On the yearLast 8 years
Operating cash flow392278206+41.0%
Capital expenditure53.410624.0-49.6%
Free cash flow339172182+96.7%
Free cash flow margin32.2%19.7%30.2%
Cash from investing-300-305-236
Cash from financing-66.298.0119
Depreciation and amortisation34.625.113.0+37.8%
Share-based compensation97.076.636.3+26.5%
Buybacks1500.00.0
Diluted shares, weighted353m359m351m-1.8%
Shares outstanding at period end346m353mn/a-1.7%

Balance sheet

$ millionFY2009FY2008FY2007On the yearLast 8 years
Shareholders' equity1,5371,267889+21.4%
Other liabilities272208n/a+31.1%
Total liabilities and equity1,8101,475n/a+22.7%
Fixed assets126117n/a+7.5%
Goodwill111111n/a0.0%
Intangible assets56.256.2n/a+0.0%
Investments951707n/a+34.4%
Trading assets62.2n/an/a
Cash and equivalents221195123+13.8%
Receivables205170n/a+20.7%
Inventory57.663.5n/a-9.2%
Other assets19.855.2n/a-64.1%
Total assets1,8101,475n/a+22.7%

10-K for the year ended 31 December 2009, filed 29 January 2010: the filing.